2-(3,4-二氯苯基)吗啉盐酸盐 | 390408-07-8

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 恶嗪烷类
• 中文名称: 2-(3,4-二氯苯基)吗啉盐酸盐
• 英文名称: 2-(3,4-dichlorophenyl)morpholine
• CAS: 390408-07-8
• 化学式: C₁₀H₁₁Cl₂NO
• mdl: MFCD11646248
• 分子量: 232.109
• InChiKey: DGBGARGNACEMSA-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.6
• 重原子数：
  14
• 可旋转键数：
  1
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.4
• 拓扑面积：
  21.3
• 氢给体数：
  1
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  2-(3,4-二氯苯基)吗啉盐酸盐 、 4-(methylamino-t-butylcarbonyl)-aniline isocyanate 以 二氯甲烷 为溶剂， 生成 2-(3,4-dichlorophenyl)-N-[4-[(2,2-dimethylpropanoylamino)methyl]phenyl]morpholine-4-carboxamide
  参考文献：
  名称：

  Discovery and initial structure–Activity relationships of trisubstituted ureas as thrombin receptor (PAR-1) antagonists

  摘要：

  Thrombin is the most potent agonist of platelet activation, and its effects are predominantly mediated by platelet thrombin receptors. Therefore, antagonists of the thrombin receptor have potential utility for the treatment of thrombotic disorders. Screening of combinatorial libraries revealed 2 to be a potent antagonist of the thrombin receptor. Modifications of this structure produced 11k, which inhibits thrombin receptor stimulated secretion and aggregation of platelets. (C) 2001 Elsevier Science Ltd. All rights reserved.

  DOI：

  10.1016/s0960-894x(01)00538-8
• 作为产物：
  描述：

  2-溴-3',4'-二氯苯乙酮 在 sodium tetrahydroborate 、 1-氯乙基氯甲酸酯 作用下， 以 甲醇 、 二氯甲烷 、 乙腈 为溶剂， 生成 2-(3,4-二氯苯基)吗啉盐酸盐
  参考文献：
  名称：

  Discovery and initial structure–Activity relationships of trisubstituted ureas as thrombin receptor (PAR-1) antagonists

  摘要：

  Thrombin is the most potent agonist of platelet activation, and its effects are predominantly mediated by platelet thrombin receptors. Therefore, antagonists of the thrombin receptor have potential utility for the treatment of thrombotic disorders. Screening of combinatorial libraries revealed 2 to be a potent antagonist of the thrombin receptor. Modifications of this structure produced 11k, which inhibits thrombin receptor stimulated secretion and aggregation of platelets. (C) 2001 Elsevier Science Ltd. All rights reserved.

  DOI：

  10.1016/s0960-894x(01)00538-8

文献信息

• HETEROCYCLIC DERIVATIVES AS MODULATORS OF ION CHANNELS
  申请人：Stamos Dean

  公开号：US20090131440A1

  公开（公告）日：2009-05-21

  The present invention relates to heterocyclic derivatives useful as inhibitors of ion channels. The invention also provides pharmaceutically acceptable compositions comprising the compounds of the invention and methods of using the compositions in the treatment of various disorders.

  本发明涉及用作离子通道抑制剂的杂环衍生物。该发明还提供了包含本发明化合物的药学上可接受的组合物，以及使用这些组合物治疗各种疾病的方法。
• PYRROLIDINONE BENZENESULFONAMIDE DERIVATIVES AS MODULATORS OF ION CHANNELS FOR THE TREATMENT OF PAIN
  申请人：Stamos Dean

  公开号：US20120010416A1

  公开（公告）日：2012-01-12

  The present invention relates to heterocyclic derivatives useful as inhibitors of ion channels. The invention also provides pharmaceutically acceptable compositions comprising the compounds of the invention and methods of using the compositions in the treatment of various disorders.

  本发明涉及杂环衍生物，其作为离子通道抑制剂具有用途。本发明还提供了包含本发明化合物的药学上可接受的组合物，并提供了使用这些组合物治疗各种疾病的方法。
• Pyrrolidinone Benzenesulfonamide Derivatives as Modulators of Ion Channels
  申请人：Vertex Pharmaceuticals Incorporated

  公开号：US20130338119A1

  公开（公告）日：2013-12-19

  The present invention relates to heterocyclic derivatives useful as inhibitors of ion channels. The invention also provides pharmaceutically acceptable compositions comprising the compounds of the invention and methods of using the compositions in the treatment of various disorders.

  本发明涉及杂环衍生物，其作为离子通道抑制剂有用。本发明还提供了包括本发明化合物的药学上可接受的组合物以及使用这些组合物治疗各种疾病的方法。
• Carbostyril derivatives
  申请人：OTSUKA PHARMACEUTICAL CO., LTD.

  公开号：EP0382185B1

  公开（公告）日：1994-06-15
• OXYTOCIN ANTAGONIST
  申请人：OTSUKA PHARMACEUTICAL CO., LTD.

  公开号：EP0602209A1

  公开（公告）日：1994-06-22